Enrolling Now - 2
"Cognitive and behavioral effects of perampanel (Fycompa) As adjunctive therapy in patients with partial epilepsy."
PI: Marcelo Lancman, MD
Sponsor: NEREG
Collaborator: Eisai, Inc
Study Duration: 24 weeks
Number of visits: 5
Eligibility Criteria:
* Age 18-70
* Native English speaker or balanced bilingual
* Diagnosis of refractory partial onset epilepsy
* Seizure frequency of 1 or more seizure per month on average during 6 months prior to visit 1
* Able and willing to provide written informed consent form
Key Exclusion Criteria:
* History of drug/alcohol abuse
* Prior history of traumatic brain injury
* Severe renal disease
* IQ less than 70
* Diagnosis of PNES
* Suicidal plan or intent in the last 6 months